-
1
المؤلفون: Cornelis J. A. Punt, Petronella O. Witteveen, Jane Robertson, Juliane M. Jürgensmeier, Hester van Cruijsen, Emile E. Voest, Thomas A. Puchalski, Martijn R. Meijerink, Giuseppe Giaccone, Klaas Hoekman, Owain Saunders, Carla M.L. van Herpen
المساهمون: Other departments, Medical oncology, Radiology and nuclear medicine, CCA - Innovative therapy
المصدر: van Cruijsen, H, Voest, E E, Punt, C J A, Hoekman, K, Witteveen, P O, Meijerink, M R, Puchalski, T A, Robertson, J, Saunders, O, Jurgensmeier, J M, van Herpen, C M L & Giaccone, G 2010, ' Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours ', European Journal of Cancer, vol. 46, no. 5, pp. 901-911 . https://doi.org/10.1016/j.ejca.2009.12.023Test
European journal of cancer (Oxford, England, 46(5), 901-911. Elsevier Limited
European Journal of Cancer, 46(5), 901-911. Pergamon
European Journal of Cancer, 46, 901-11
European Journal of Cancer, 46, 5, pp. 901-11مصطلحات موضوعية: Adult, Diarrhea, Male, Cancer Research, medicine.drug_class, Pharmacology, Tyrosine-kinase inhibitor, Cediranib, Young Adult, Gefitinib, Pharmacokinetics, Translational research [ONCOL 3], Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Epidermal growth factor receptor, Adverse effect, neoplasms, Fatigue, Aged, Netherlands, biology, business.industry, Middle Aged, Anorexia, ErbB Receptors, Receptors, Vascular Endothelial Growth Factor, Treatment Outcome, Oncology, Tolerability, Pharmacodynamics, biology.protein, Quinazolines, Drug Therapy, Combination, Female, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ea4d07b6c54302e0d35aec2fb208d7Test
https://doi.org/10.1016/j.ejca.2009.12.023Test -
2
المؤلفون: Marialuisa Lavitrano, Gabriele Romano, Annamaria Cialdella, Kristian Helin, Roberto Giovannoni, M. Carola, Fabio Pisano, Leonarda Ianzano, Sara Bonomo, Donato Nitti, Emanuela Grassilli, Chelsea M. McLean, Marco Agostini, Emile E. Voest, Maria Grazia Cerrito
المصدر: European Journal of Cancer. 69:S140
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, Colorectal cancer, business.industry, medicine.medical_treatment, Null (mathematics), Drug resistance, medicine.disease, 03 medical and health sciences, 030104 developmental biology, Apoptosis, Internal medicine, medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::941b45d73a8c284d70dfcdee9a41df70Test
https://doi.org/10.1016/s0959-8049Test(16)33016-7 -
3
المصدر: European Journal of Cancer. 51:S229
مصطلحات موضوعية: Cancer Research, Oncology, business.industry, medicine, Cancer, Computational biology, medicine.disease, business, DNA sequencing
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c743e40293c2575b727ea41e91c42c4cTest
https://doi.org/10.1016/s0959-8049Test(16)30663-3 -
4
المؤلفون: Petronella O. Witteveen, Jantien Wanders, K. Law, J.H.M. Schellens, Lot A. Devriese, G. Edwards, J. H. Beijnen, Larisa Reyderman, Serena Marchetti, Emile E. Voest
المصدر: European Journal of Cancer. 47:S157
مصطلحات موضوعية: Eribulin Mesylate, Cancer Research, Oncology, Pharmacokinetics, business.industry, Medicine, In patient, Pharmacology, business, Rifampicin, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::146be98f1b436244d287faac3708e048Test
https://doi.org/10.1016/s0959-8049Test(11)70855-3 -
5
المؤلفون: M. Bontendal, Otilia Dalesio, D.J. Richel, P. Hupperets, M. Nooij, Emile E. Voest, E. van der Wall, Sjoerd Rodenhuis, A. M. Westermann, E.G.E. de Vries, Lvam Beex
المصدر: European Journal of Cancer. 37:S285
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, High dose chemotherapy, Breast cancer, business.industry, Internal medicine, medicine, Cancer, medicine.disease, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2d977c6ddc632578c8e9a8da406cb155Test
https://doi.org/10.1016/s0959-8049Test(01)81541-0